Drawing for REPLICART

USPTO serial 87460253

REPLICART

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CHIANG, TIFFANY YOUNG
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REPLICART?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.1100 NEW YORK AVENUE, N.W.WASHINGTON, DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention, management, diagnosis and treatment of osteoarthritis; veterinary preparations for the prevention, management, diagnosis and treatment of osteoarthritis; biotechnology preparations in the nature of biopharmaceuticals for the prevention, management, diagnosis and treatment of osteoarthritis; and medical preparations in the nature of pharmaceutical preparations for the prevention, management, diagnosis and treatment of osteoarthritis; diagnostic preparations and reagents for medical purposes but not including preparations and reagents for embryonic stem cells; culture fluids, namely, cultures of micro-organisms for medical purposes but not including cultures for embryonic stem cells; human allograft tissue but not including embryonic stem cells; animal allograft tissue but not including embryonic stem cells; human tissue and animal tissue for transplantation or implantation, and medical and surgical purposes but not including embryonic stem cells; human cells, namely, stem cells but not including embryonic stem cells for medical use; animal cells, namely, stem cells for medical or clinical use but not embryonic stem cells; pharmaceutical preparations for the treatment, reconstruction and repair of tissue but not including preparations for embryonic stem cells; all of the foregoing excluding vitamins, minerals, nutritional supplements and foodstuffs in this classACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 26, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 26, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 29, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 28, 2020EX5GSOU EXTENSION 5 GRANTED—
Sep 28, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 21, 2020EXT5SOU EXTENSION 5 FILED—
Sep 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 6, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 4, 2020EX4GSOU EXTENSION 4 GRANTED—
Feb 4, 2020EXT4SOU EXTENSION 4 FILED—
Feb 4, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 19, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 17, 2019EX3GSOU EXTENSION 3 GRANTED—
Sep 17, 2019EXT3SOU EXTENSION 3 FILED—
Sep 17, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 20, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 18, 2019EX2GSOU EXTENSION 2 GRANTED—
Mar 18, 2019EXT2SOU EXTENSION 2 FILED—
Mar 18, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 22, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 20, 2018EX1GSOU EXTENSION 1 GRANTED—
Sep 20, 2018EXT1SOU EXTENSION 1 FILED—
Sep 20, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 20, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 20, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 23, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 23, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 3, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 4, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 30, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2017DOCKASSIGNED TO EXAMINER—
May 30, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 26, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance